The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial Fibrillation
Open accessAbstract
BACKGROUND AND OBJECTIVES: Although generally recommended in atrial fibrillation (AF) patients, the effectiveness and safety of oral anticoagulation in dialysis patients with AF is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We assembled a cohort of older hemodialysis patients who initiated dialysis without prior record of AF and who had prescription drug benefits through three state-administered programs. The index event was a first hospitalization with diagnosed AF; patients with any recorded prior warfarin use were excluded. Eligible patients survived ≥30 days from discharge, and new warfarin use was recorded from prescription records during that 30-day window. Propensity-matched warfarin users and nonusers were compared using Cox regression. Outcomes included ischemic stroke, hemorrhagic stroke, and mortality. RESULTS: Among 2313 patients with new AF who survived 30 days from discharge, 249 (10.8%) filled a prescription for warfarin. Comparing 237 warfarin users and 948 propensity-matched nonusers over 2287 person-years of follow-up, the occurrence of ischemic stroke was similar (HR = 0.92; 95% CI, 0.61 to 1.37), whereas warfarin users experienced twice the risk of hemorrhagic stroke (HR = 2.38; 95% CI, 1.15 to 4.96). The risks of stroke, gastrointestinal hemorrhage, and mortality did not differ between groups. As-treated analyses yielded similar findings, as did analyses restricted to patients with CHADS(2) scores ≥2. CONCLUSIONS: Although we confirmed association between warfarin use and hemorrhagic stroke in dialysis patients with AF, we found no association between warfarin use and ischemic stroke. Adequately powered randomized trials are required to conclusively determine the risks and benefits of the studied warfarin indication in hemodialysis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Warfarin use was associated either with a neutral or increased risk of stroke in database analyses of patients on dialysis, [419][420][421] including a population-based analysis in Canada (adjusted HR for stroke 1.14; 95% CI 0.78-1.67,adjusted HR for bleeding 1.44; 95% CI 1.13-1.85).422”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [421]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors
Birman-Deych, E., Waterman, A. D., Yan, Y., Nilasena, D. S., Radford, M. J., & Gage, B. F. (2005) · Medical Care · doi:10.1097/01.mlr.0000160417.39497.a9 · Cited by 723
Kokotailo, R., & Hill, M. D. (2005) · Stroke · doi:10.1161/01.str.0000174293.17959.a1 · Cited by 717
Chan, K. E., Lazarus, J. M., Thadhani, R., & Hakim, R. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030319 · Cited by 431 · cited 1×
“Our findings differ from those observed in a recent study of 1671 patients who already had AF when starting hemodialysis with a national dialysis provider and survived 90 days from initiation (7).”
ResultElevated risk of stroke among patients with end-stage renal disease
Seliger, S. L., Gillen, D. L., Longstreth, W. T., Kestenbaum, B. R., & Stehman‐Breen, C. O. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00101.x · Cited by 426
Wizemann, V., Tong, L., Satayathum, S., Disney, A., Akiba, T., Fissell, R. B., Kerr, P. G., Young, E. W., & Robinson, B. M. (2010) · Kidney International · doi:10.1038/ki.2009.477 · Cited by 408
Accuracy of ICD-9-CM Coding for the Identification of Patients With Acute Ischemic Stroke
Goldstein, L. B. (1998) · Stroke · doi:10.1161/01.str.29.8.1602 · Cited by 408
The Increasing Prevalence of Atrial Fibrillation among Hemodialysis Patients
Winkelmayer, W. C., Patrick, A. R., Liu, J., Brookhart, M. A., & Setoguchi, S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050459 · Cited by 275
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,072
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
January, C. T., Wann, L. S., Calkins, H. G., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.011 · Cited by 2,252
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.021 · Cited by 581
Siontis, K. C., Zhang, X., Eckard, A., Bhave, N. M., Schaubel, D. E., He, K., Tilea, A. M., Stack, A. G., Balkrishnan, R., Yao, X., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035418 · Cited by 499
January, C. T., Wann, L. S., Calkins, H. G., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.01.024 · Cited by 414
Shah, M., Tsadok, M. A., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., Humphries, K. H., Tu, J. V., Behlouli, H., Guo, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004777 · Cited by 340
Brieger, D. B., Amerena, J. V., Attia, J., Bajorek, B. V., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T. L., Haqqani, H. M., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 335
Zimmerman, D. L., Sood, M. M., Rigatto, C., Holden, R. M., Hiremath, S. S., & Clase, C. M. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs416 · Cited by 308
Bonde, A. N., Lip, G. Y. H., Kamper, A., Hansen, P. R., Lamberts, M., Hommel, K., Hansen, M. L., Gislason, G., Torp-Pedersen, C. T., & Olesen, J. B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.051 · Cited by 285
Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
Mavrakanas, T. A., Samer, C. F., Nessim, S. J., Frisch, G., & Lipman, M. L. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016090980 · Cited by 231
Chan, K. E., Giugliano, R. P., Patel, M. R., Abramson, S., Jardine, M., Zhao, S. J., Perkovic, V., Maddux, F. W., & Piccini, J. P. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.082 · Cited by 231
Dahal, K. B., Kunwar, S., Rijal, J. P., Schulman, P. M., & Lee, J. (2015) · CHEST Journal · doi:10.1378/chest.15-1719 · Cited by 226
Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease
Tonelli, M. A., Karumanchi, S. A., & Thadhani, R. (2016) · Circulation · doi:10.1161/circulationaha.115.018713 · Cited by 219
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
Chiang, C., Okumura, K., Zhang, S., Chao, T., Siu, C., Lim, T. W., Saxena, A., Takahashi, Y., & Teo, W. S. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.05.004 · Cited by 200
Reinecke, H., Engelbertz, C. M., Bauersachs, R. M., BREITHARDT, G. E., Echterhoff, H.-H., Gerß, J., Hæusler, K. G., Hewing, B., Hoyer, J. D., Juergensmeyer, S., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.062779 · Cited by 202
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation
Kumar, S., Lim, E., Covic, A. C., Verhamme, P. B., Gale, C. P., Camm, A. J., & Goldsmith, D. J. A. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.1031 · Cited by 182
Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis
Kuno, T., Takagi, H., Ando, T., Sugiyama, T., Miyashita, S., Valentin, N., Shimada, Y. J., Kodaira, M., Numasawa, Y., Briasoulis, Α., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.059 · Cited by 174
Friberg, L., Benson, L., & Lip, G. Y. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu139 · Cited by 161
Carrero, J. J., Evans, M., Szummer, K. E., Spaak, J., Lindhagen, L., Edfors, R., Stenvinkel, P., Jacobson, S. H., & Jernberg, T. (2014) · JAMA · doi:10.1001/jama.2014.1334 · Cited by 159
2018 Korean Guideline of Atrial Fibrillation Management
Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 157
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.057 · Cited by 145
Randhawa, M. S., Vishwanath, R., Rai, M. P., Wang, L., Randhawa, A. K., Abela, G. S., & Dhar, G. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2175 · Cited by 149
Jun, M., James, M. T., Manns, B. J., Quinn, R. R., Ravani, P., Tonelli, M., Perkovic, V., Winkelmayer, W. C., Ma, Z., Hemmelgarn, B. R., et al. (2015) · BMJ · doi:10.1136/bmj.h246 · Cited by 143
Self-citationPathophysiology of atrial fibrillation and chronic kidney disease
Ding, W. Y., Gupta, D., Wong, C. F., & Lip, G. Y. H. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa258 · Cited by 144
Shen, J. I., Montez‐Rath, M. E., Lenihan, C. R., Turakhia, M. P., Chang, T. I., & Winkelmayer, W. C. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.019 · Cited by 136
Self-citationChronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study
Ocak, G., Rookmaaker, M. B., Algra, A., de Borst, G. J., Doevendans, P. A., Kappelle, L. J., Verhaar, M. C., Visseren, F. L. J., van der Graaf, Y., Grobbee, D. E., et al. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13904 · Cited by 130
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Potpara, T., Ferro, C. J., & Lip, G. Y. H. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.19 · Cited by 130
Safety and effectiveness of apixaban compared to warfarin in dialysis patients
Reed, D. R., Palkimas, S., Hockman, R. H., Abraham, S., Le, T. M., & Maitland, H. S. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12083 · Cited by 111
Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation
Genovesi, S., Rossi, E., Gallieni, M. A., Stella, A., Badiali, F., Conte, F., Pasquali, S., Bertoli, S. V., Ondei, P., Bonforte, G., et al. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu334 · Cited by 108
Mavrakanas, T. A., Garlo, K. G., & Charytan, D. M. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11650919 · Cited by 104
Dad, T., & Weiner, D. E. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.06.003 · Cited by 102
Meersch, H. V. D., Bacquer, D. D., & Vriese, A. S. D. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.09.016 · Cited by 96
Tan, J., Liu, S., Segal, J. B., Alexander, G. C., & McAdams‐DeMarco, M. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0368-6 · Cited by 95
Use and Safety of Unfractionated Heparin for Anticoagulation During Maintenance Hemodialysis
Shen, J. I., & Winkelmayer, W. C. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.03.017 · Cited by 91
Self-citationLiao, J., Chao, T., Liu, C., Wang, K.-L., Chen, S., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., et al. (2015) · Kidney International · doi:10.1038/ki.2014.393 · Cited by 90
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease
Hart, R. G., Eikelboom, J. W., Brimble, K. S., McMurtry, M. S., & Ingram, A. J. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.04.005 · Cited by 89
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-2103 · Cited by 87
Königsbrügge, O., Posch, F., Antlanger, M., Kovařík, J., Klauser‐Braun, R., Kletzmayr, J., Schmaldienst, S., Auinger, M., Zuntner, G., Lorenz, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169400 · Cited by 83
Szummer, K. E., Gasparini, A., Eliasson, S., Ärnlöv, J., Qureshi, A. R., Barany, P. F., Evans, M., Friberg, L., & Carrero, J. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004925 · Cited by 88
Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
Ng, K. P., Edwards, N. C., Lip, G. Y. H., Townend, J., & Ferro, C. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.381 · Cited by 82
Harel, Z., Chertow, G. M., Shah, P. S., Harel, S., Dorian, P., Yan, A. T.-K., Saposnik, G., Sood, M. M., Molnar, A. O., Perl, J. M., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.02.004 · Cited by 79
Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation
Shih, C.-J., Ou, S., Chao, P.-W., Kuo, S., Lee, Y.-J., Yang, C., Tarng, D., Lin, C., Huang, P., Li, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018294 · Cited by 78
Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation
Song, J., Navarro‐García, J. A., Wu, J., Saljic, A., Abu-Taha, I., Li, L., Lahiri, S. K., Keefe, J. A., Aguilar-Sánchez, Y., Moore, O. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167517 · Cited by 76
Anticoagulants in atrial fibrillation patients with chronic kidney disease
Hart, R. G., Eikelboom, J. W., Ingram, A. J., & Herzog, C. A. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.160 · Cited by 75
Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis
Findlay, M., Thomson, P. C., Fulton, R. L., Solbu, M. D., Jardine, A. G., Patel, R. K., Stevens, K. K., Geddes, C., Dawson, J., & Mark, P. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009095 · Cited by 75
Chokesuwattanaskul, R., Thongprayoon, C., Tanawuttiwat, T., Kaewput, W., Pachariyanon, P., & Cheungpasitporn, W. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13331 · Cited by 69
Wakasugi, M., Kazama, J. J., Tokumoto, A., Suzuki, K., Kageyama, S., Ohya, K., Miura, Y., Kawachi, M., Takata, T., Nagai, M., et al. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0885-6 · Cited by 66
Providencia, R. A., Marijon, É., Bovéda, S., Barra, S., Narayanan, K., Heuzey, J. L., Gersh, B. J., & Gonçalves, L. M. M. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.048 · Cited by 67
Atrial fibrillation and risk of stroke in dialysis patients
Wetmore, J. B., Ellerbeck, E. F., Mahnken, J. D., Phadnis, M. A., Rigler, S. K., Mukhopadhyay, P., Spertus, J. A., Zhou, X., Hou, Q., & Shireman, T. I. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.12.011 · Cited by 65
Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000018 · Cited by 62
Risk of Stroke in Patients with ESRD
Masson, P., Kelly, P. J., Craig, J. C., Lindley, R. I., & Webster, A. C. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12001214 · Cited by 60
Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.521 · Cited by 58
A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease
Parker, K., Hartemink, J., Saha, A., Mitra, R., Lewis, P. J., Power, A. J., Choudhuri, S., Mitra, S., & Thachil, J. V. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01413-x · Cited by 61
Chronic Kidney Disease and Stroke
Husseini, N. E., Kaskar, O. B., & Goldstein, L. B. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.09.001 · Cited by 57
Wang, T. K. M., Sathananthan, J., Marshall, M. R., Kerr, A., & Hood, C. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.08.012 · Cited by 57
Chan, P., Huang, D., Yip, P.-S., Hai, J. J., Tse, H., Chan, T. M., Lip, G. Y. H., Lo, W.-K., & Siu, C. (2015) · EP Europace · doi:10.1093/europace/euv289 · Cited by 55
Bleeding risk of haemodialysis and peritoneal dialysis patients
van der Sluijs, A. V. E., Abrahams, A. C., Rookmaaker, M. B., Verhaar, M. C., Bos, W. J. W., Blankestijn, P. J., Dekker, F. W., van Diepen, M., & Ocak, G. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa216 · Cited by 58
Outcomes After Kidney Transplantation of Patients Previously Diagnosed With Atrial Fibrillation
Lenihan, C. R., Montez‐Rath, M. E., Scandling, J. D., Turakhia, M. P., & Winkelmayer, W. C. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12197 · Cited by 54
Self-citationSu, X., Yan, B., Wang, L., Lv, J., Cheng, H., & Chen, Y. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.02.328 · Cited by 54
Guo, Y., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.179 · Cited by 53
Performance of bleeding risk scores in dialysis patients
Ocak, G., Ramspek, C. L., Rookmaaker, M. B., Blankestijn, P. J., Verhaar, M. C., Bos, W. J. W., Dekker, F. W., & van Diepen, M. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy387 · Cited by 53
Pokorney, S. D., Black‐Maier, E., Hellkamp, A. S., Friedman, D. J., Vemulapalli, S., Granger, C. B., Thomas, L. E., Peterson, E. D., & Piccini, J. P. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.019 · Cited by 54
Nochaiwong, S., Ruengorn, C., Awiphan, R., Dandecha, P., Noppakun, K., & Phrommintikul, A. (2016) · Open Heart · doi:10.1136/openhrt-2016-000441 · Cited by 52
Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.003 · Cited by 52
Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
Herrington, W. G., Haynes, R., Staplin, N., Emberson, J., Baigent, C., & Landray, M. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12281 · Cited by 51
Evidence-Based Cardiology in Hemodialysis Patients
Allon, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060632 · Cited by 52
Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis
Yoon, C.-Y., Noh, J., Jhee, J. H., Chang, T. I., Kang, E. W., Kee, Y. K., Kim, H., Park, S., Yun, H., Jung, S.-Y., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.017114 · Cited by 46
Cardiovascular complications in chronic dialysis patients
Mavrakanas, T. A., & Charytan, D. M. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000280 · Cited by 45
Kai, B., Bogorad, Y., Nguyen, L.-A., Yang, S.-J., Chen, W., Spencer, H. T., Shen, A. Y., & Lee, M. S. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.01.047 · Cited by 44
Arnson, Y., Hoshen, M., Senderey, A. B., Reges, O., Balicer, R. D., Leibowitz, M., Tsadok, M. A., & Haim, M. (2020) · Cardiology · doi:10.1159/000504877 · Cited by 43
Miao, B., Sood, N. A., Bunz, T. J., & Coleman, C. I. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13383 · Cited by 42
Jun, M., James, M. T., Ma, Z., Zhang, J., Tonelli, M. A., McAlister, F. A., Manns, B., Ravani, P., Quinn, R. R., Wiebe, N., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.018 · Cited by 42
Self-citationOral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
Hu, A. H., Niu, J., & Winkelmayer, W. C. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.08.006 · Cited by 42
Self-citationKao, T., Chen, Z., & Lin, Y. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034176 · Cited by 42
Evaluating time in therapeutic range for hemodialysis patients taking warfarin
Quinn, L. M., Richardson, R., Cameron, K., & Battistella, M. (2014) · Clinical Nephrology · doi:10.5414/cn108400 · Cited by 42
Washam, J. B., Holmes, D. N., Thomas, L. E., Pokorney, S. D., Hylek, E. M., Fonarow, G. C., Mahaffey, K. W., Gersh, B. J., Kowey, P. R., Ansell, J., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008928 · Cited by 37
Li, J., Wang, L., Hu, J., & Xu, G. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.03.013 · Cited by 35
Management of atrial fibrillation in chronic kidney disease: Double trouble
Nimmo, C., Wright, M. J., & Goldsmith, D. J. A. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.010 · Cited by 35
Lullo, L. D., Ronco, C., Cozzolino, M. G., Russo, D., Russo, L., Iorio, B. R. D., Pascalis, A. D., Bàrbera, V., Galliani, M., Vitaliano, E., et al. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.04.027 · Cited by 34
Lin, Y., Chen, B.-L., Shih, C., Lin, F., Chen, C., Hsu, C., Kao, Y., Bi, W., Chen, L.-Y., Chien, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249940 · Cited by 34
Anticoagulation for atrial fibrillation in patients on dialysis
Shen, J. I., Turakhia, M. P., & Winkelmayer, W. C. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835856fd · Cited by 33
Self-citationBansal, V., Herzog, C. A., Sarnak, M. J., Choi, M. J., Mehta, R. L., Jaar, B. G., Rocco, M. V., & Kramer, H. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.08.003 · Cited by 33
Clase, C. M., Holden, R. M., Sood, M. M., Rigatto, C., MOIST, L. M., Thomson, A. B. R., Mann, J. F. E., & Zimmerman, D. L. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs346 · Cited by 32
The atrial fibrillation conundrum in dialysis patients
Vriese, A. S. D., Caluwé, R., & Raggi, P. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.01.010 · Cited by 32
Tan, J., Bae, S., Segal, J. B., Zhu, J., Alexander, G. C., Segev, D. L., & McAdams‐DeMarco, M. (2017) · Nephrology · doi:10.1111/nep.13207 · Cited by 32
Use and safety of heparin-free maintenance hemodialysis in the USA
Shen, J. I., Mitani, A., Chang, T. I., & Winkelmayer, W. C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft067 · Cited by 31
Self-citationWong, C. X. J., Odutayo, A., Emdin, C. A., Kinnear, N. J., & Sun, M. T. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.03.042 · Cited by 31
Intersection of cardiovascular disease and kidney disease
Bansal, N., Hsu, C., & Go, A. S. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000444820.80249.56 · Cited by 30
Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation
Liu, G., Long, M., Hu, X., Hu, C.-H., Liao, X., Du, Z.-M., & Dong, Y. (2015) · Medicine · doi:10.1097/md.0000000000002233 · Cited by 29
Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?
Małyszko, J., Łopatowska, P., Młodawska, E., Musiałowska, D., Małyszko, J. S., & Tomaszuk−Kazberuk, A. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx265 · Cited by 29
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con
Keskar, V. S., & Sood, M. M. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03200316 · Cited by 28
Metadata
- Authors
- Winkelmayer, W. C., Liu, J., Setoguchi, S., & Choudhry, N. K.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Liu, Jun
- Setoguchi, Soko
- Choudhry, Niteesh K.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2011-11
- Volume
- 6
- Issue
- 11
- Pages
- 2662-2668
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC3206003
- OpenAlex
- W2100505398
- Cited by
- 280
- References
- 17
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 9 · 2023: 10 · 2022: 15 · 2021: 8 · 2020: 12 · 2019: 16 · 2018: 29 · 2017: 33 · 2016: 37 · 2015: 30 · 2014: 37 · 2013: 21 · 2012: 13
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- School of Medicine, Stanford University
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK077336)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- warfarin, atrial fibrillation, hemodialysis, older adults, oral anticoagulation, hemorrhagic stroke, ischemic stroke, gastrointestinal bleeding, mortality, CHADS2 score, anticoagulation initiation
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Anticoagulants, Atrial Fibrillation, Brain Ischemia, Female, Medicare, Renal Dialysis, Hospitalization, Humans, Kidney Failure, Chronic, Male, Middle Aged, Drug Prescriptions, Risk Factors, Time Factors, United States, Warfarin, Survival Rate, Logistic Models, Proportional Hazards Models, Case-Control Studies, Treatment Outcome, Risk Assessment, Intracranial Hemorrhages, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
